$145.16
0[0.00%]
At close: Apr 18
$145.16
0[0.00%]
PreMarket: 4:31PM EDT
Alnylam Pharmaceuticals
(NASDAQ:ALNY)Alnylam Pharmaceuticals Stock (NASDAQ:ALNY), Earnings Estimates, EPS, and Revenue
Alnylam Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 2
EPS Estimate
$-1.180
Quarterly Revenue Estimate
$426.5M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$1.8B
Analyze the earnings history of Alnylam Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/02/2024 | AM | ALNY | Q1 | -$1.06 | -$1.18 | — | — | $319.29M | $426.51M | — | — | Get Alert |
| 02/15/2024 | AM | ALNY | Q4 | -$1.39 | -$1.33 | -$0.77 | 42.11% | $335.04M | $442.90M | $439.72M | -0.72% | Get Alert |
| 11/02/2023 | AM | ALNY | Q3 | -$1.58 | -$1.36 | $1.74 | 227.94% | $264.31M | $401.03M | $750.53M | 87.15% | Get Alert |
| 08/03/2023 | AM | ALNY | Q2 | -$2.03 | -$1.72 | -$1.62 | 5.81% | $224.82M | $331.73M | $318.75M | -3.91% | Get Alert |
| 05/04/2023 | AM | ALNY | Q1 | -$1.49 | -$1.76 | -$1.06 | 39.77% | $213.26M | $312.26M | $319.29M | 2.25% | Get Alert |
| 02/23/2023 | AM | ALNY | Q4 | -$1.74 | -$1.90 | -$1.39 | 26.84% | $258.54M | $313.13M | $335.04M | 7.00% | Get Alert |
| 10/27/2022 | AM | ALNY | Q3 | -$1.59 | -$1.78 | -$1.58 | 11.24% | $187.63M | $293.03M | $264.31M | -9.80% | Get Alert |
| 07/28/2022 | AM | ALNY | Q2 | -$1.30 | -$1.62 | -$2.03 | -25.31% | $220.55M | $255.88M | $224.82M | -12.14% | Get Alert |
| 04/28/2022 | AM | ALNY | Q1 | -$1.64 | -$1.84 | -$1.49 | 19.02% | $135.77M | $243.02M | $213.26M | -12.25% | Get Alert |
| 02/10/2022 | AM | ALNY | Q4 | -$1.60 | -$1.54 | -$1.69 | -9.74% | $163.56M | $233.62M | $258.54M | 10.66% | Get Alert |
| 10/28/2021 | AM | ALNY | Q3 | -$1.58 | -$1.57 | -$1.51 | 3.82% | $125.85M | $218.69M | $187.63M | -14.20% | Get Alert |
| 08/03/2021 | AM | ALNY | Q2 | -$1.67 | -$1.60 | -$1.30 | 18.75% | $103.96M | $193.18M | $220.55M | 14.17% | Get Alert |
| 04/29/2021 | AM | ALNY | Q1 | -$1.52 | -$1.75 | -$1.64 | 6.29% | $99.48M | $168.74M | $177.57M | 5.23% | Get Alert |
| 02/11/2021 | AM | ALNY | Q4 | -$1.98 | -$1.76 | -$1.60 | 9.09% | $71.68M | $146.07M | $163.56M | 11.98% | Get Alert |
| 11/05/2020 | AM | ALNY | Q3 | -$1.50 | -$1.66 | -$1.58 | 4.82% | $70.06M | $120.75M | $125.85M | 4.23% | Get Alert |
| 08/06/2020 | AM | ALNY | Q2 | -$1.83 | -$1.74 | -$1.67 | 4.02% | $44.71M | $99.48M | $103.96M | 4.51% | Get Alert |
| 05/06/2020 | AM | ALNY | Q1 | -$1.73 | -$1.89 | -$1.52 | 19.58% | $33.29M | $91.56M | $99.48M | 8.65% | Get Alert |
| 02/06/2020 | AM | ALNY | Q4 | -$1.82 | -$2.23 | -$1.98 | 11.21% | $21.03M | $72.00M | $71.68M | -0.44% | Get Alert |
| 10/31/2019 | AM | ALNY | Q3 | -$1.56 | — | -$1.50 | — | $2.07M | — | $70.06M | — | Get Alert |
FAQ
When is Alnylam Pharmaceuticals (NASDAQ:ALNY) reporting earnings?
Alnylam Pharmaceuticals (ALNY) is scheduled to report earnings on May 2, 2024. The last reported earnings were for reported on February 15, 2024 for Q4.
What were the latest earnings per share (EPS) for Alnylam Pharmaceuticals (NASDAQ:ALNY)?
The Actual EPS was $-0.77, which beat the estimate of $-1.33.
What were Alnylam Pharmaceuticals’s (NASDAQ:ALNY) revenues?
The Actual Revenue was $439.7M, which missed the estimate of $442.9M.
Browse earnings estimates, EPS, and revenue on all stocks.